glp-1 physiology informs the pharmacotherapy of obesity effect GLP-1R agonists on the medical triad of obesity, diabetes, and cancer | Cancer and Metastasis Reviews Frontiers | GLP-1 agonists and

EFSA (2020) Scientific opinion on the risks to public health related to the presence of ochratoxin A in food

9,10 GLP-1 receptor agonists (GLP-1RAs) are a class of drugs designed to mimic endogenous GLP-1 and bind to its receptors to promote glucose homeostasis in patients with T2D

At present, about 17% of supplements have shown effectiveness in improving sperm health

Achieving a stable and euthyroid (normal thyroid function) state is important because untreated or undertreated hypothyroidism can blunt the metabolic benefits of GLP-1 medications, such as weight loss and improved blood sugar control

Anecdotal reports of success with interferon alfa (INF-A) or hyperfractionated radiation therapy exist